Diagnosis and treatment of T/myeloid mixed phenotype acute leukaemia (T/M-MPAL).
作者信息
Xu Ke, Abusalim Enas, Vitsaras Evan, Orfinada Karen, Baker Robert, Nacheva Elisabeth, Wilson Andrew, O'Nions Jenny, Gupta Rajeev
机构信息
Department of Haematology University College London Hospital NHS Foundation Trust University College London London UK.
Specialist Integrated Haematology Malignancy Diagnostic Service Health Services Laboratories University College London Hospitals NHS Foundation Trust University College London London UK.
出版信息
EJHaem. 2025 Jan 10;6(1):e1075. doi: 10.1002/jha2.1075. eCollection 2025 Feb.
Abstract
摘要
相似文献
1
Diagnosis and treatment of T/myeloid mixed phenotype acute leukaemia (T/M-MPAL).
EJHaem. 2025 Jan 10;6(1):e1075. doi: 10.1002/jha2.1075. eCollection 2025 Feb.
2
Multiparametric Flow Cytometry in Mixed Phenotype Acute Leukemia.
Indian J Hematol Blood Transfus. 2019 Jul;35(3):451-458. doi: 10.1007/s12288-019-01101-0. Epub 2019 Feb 13.
3
The genetic basis and cell of origin of mixed phenotype acute leukaemia.
Nature. 2018 Oct;562(7727):373-379. doi: 10.1038/s41586-018-0436-0. Epub 2018 Sep 12.
4
[Clinical Characteristics of Patients with Ph Mixed Phenotype Acute Leukemia].
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2019 Apr;27(2):354-359. doi: 10.19746/j.cnki.issn.1009-2137.2019.02.007.
5
T/myeloid mixed phenotype acute leukaemia harbouring TLX3::BCL11B with TLX3 activation.
Br J Haematol. 2024 Aug;205(2):607-612. doi: 10.1111/bjh.19363. Epub 2024 Feb 22.
6
Prognosis of children with mixed phenotype acute leukemia treated on the basis of consistent immunophenotypic criteria.
Haematologica. 2010 Jun;95(6):928-35. doi: 10.3324/haematol.2009.014506. Epub 2010 Feb 9.
7
Diagnostic challenge in mixed phenotype acute leukemia with T/megakaryocyte or T/myeloid lineages accompanied by t(3;3).
Diagn Pathol. 2022 Oct 5;17(1):74. doi: 10.1186/s13000-022-01257-w.
8
Genomic Landscape of Mixed-Phenotype Acute Leukemia.
Int J Mol Sci. 2022 Sep 24;23(19):11259. doi: 10.3390/ijms231911259.
9
Clinicopathological differences between T-lymphoblastic leukemia/lymphoma, early T-precursor lymphoblastic leukemia/lymphoma, and mixed-phenotype acute leukemia with T lineage: An analysis of 41 adult cases.
Hum Pathol. 2024 Aug;150:78-85. doi: 10.1016/j.humpath.2024.06.016. Epub 2024 Jun 28.
10
Adult mixed phenotype acute leukemia (MPAL): B/myeloid MPAL is distinct from other MPAL subtypes.
Int J Lab Hematol. 2023 Apr;45(2):170-178. doi: 10.1111/ijlh.13988. Epub 2022 Nov 2.
本文引用的文献
1
T/myeloid MPAL: origin and pathogenesis.
Blood. 2022 Jan 20;139(3):313-315. doi: 10.1182/blood.2021014129.
2
The genetic basis and cell of origin of mixed phenotype acute leukaemia.
Nature. 2018 Oct;562(7727):373-379. doi: 10.1038/s41586-018-0436-0. Epub 2018 Sep 12.
3
Integrative genomic analysis of adult mixed phenotype acute leukemia delineates lineage associated molecular subtypes.
Nat Commun. 2018 Jul 10;9(1):2670. doi: 10.1038/s41467-018-04924-z.
4
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.
Blood. 2017 Jan 26;129(4):424-447. doi: 10.1182/blood-2016-08-733196. Epub 2016 Nov 28.
5
Immunohistochemistry is a more sensitive marker for the detection of myeloperoxidase in acute myeloid leukemia compared with flow cytometry and cytochemistry.
Int J Lab Hematol. 2010 Feb;32(1 Pt 1):e132-6. doi: 10.1111/j.1751-553X.2008.01124.x. Epub 2008 Dec 10.
6
Comparison of flow cytometry and enzyme cytochemistry for the detection of myeloperoxydase in acute myeloid leukaemia: interests of a new positivity threshold.
Br J Haematol. 2003 Jul;122(2):211-6. doi: 10.1046/j.1365-2141.2003.04384.x.
7
Detection of myeloperoxidase by flow cytometry in acute leukemia.
Cytometry. 1998 Aug 15;34(4):198-202. doi: 10.1002/(sici)1097-0320(19980815)34:4<198::aid-cyto4>3.0.co;2-c.
Zotero 插件